An emerging role of the cellular prion protein as a modulator of a morphogenetic program underlying epithelial-to-mesenchymal transition by Mohadeseh Mehrabian et al.
PERSPECTIVE ARTICLE
published: 18 September 2014
doi: 10.3389/fcell.2014.00053
An emerging role of the cellular prion protein as a
modulator of a morphogenetic program underlying
epithelial-to-mesenchymal transition
Mohadeseh Mehrabian1,2, Sepehr Ehsani1,2 † and Gerold Schmitt-Ulms1,2*
1 Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada
2 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
Edited by:
Sophie Mouillet-Richard, INSERM
Unit 1124, France
Reviewed by:
Séverine Martin-Lannerée,
Université Paris Descartes,
UMR-S1124, France
Edward Málaga-Trillo, University of
Konstanz, Germany
*Correspondence:
Gerold Schmitt-Ulms, Tanz Centre
for Research in Neurodegenerative
Diseases, University of Toronto,
Krembil Discovery Tower, 60
Leonard Avenue, Toronto, ON M5T
2S8, Canada
e-mail: g.schmittulms@utoronto.ca
†Present address:
Sepehr Ehsani, Whitehead Institute
for Biomedical Research,
Cambridge, MA, USA
Knowledge of phenotypic changes the cellular prion protein (PrPC) contributes to may
provide novel avenues for understanding its function. Here we consider data from
functional knockout/down studies and protein–protein interaction analyses from the
perspective of PrP’s relationship to its ancestral ZIP metal ion transporting proteins. When
approached in this manner, a role of PrPC as a modulator of a complex morphogenetic
program that underlies epithelial-to-mesenchymal transition (EMT) emerges. To execute
EMT, cells have to master the challenge to shift from cell-cell to cell-substrate modes of
adherence. During this process, cell-cell junctions stabilized by E-cadherins are replaced
by focal adhesions that mediate cell-substrate contacts. A similar reprogramming occurs
during distinct organogenesis events that have been shown to rely on ZIP transporters. A
model is presented that sees ZIP transporters, and possibly also PrPC, affect this balance
of adherence modes at both the transcriptional and post-translational levels.
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INTRODUCTION
To someone new to the prion literature, it might be confusing
that on the one hand some researchers lament the absence of a
known function of the cellular prion protein (PrPC), while on
the other hand, there seems to be a myriad of roles assigned
to this protein (Steele et al., 2007; Aguzzi et al., 2008; Zomosa-
Signoret et al., 2008). Indeed, over the past few decades, mouse
models harboring a deletion of the prion gene have revealed
some interesting and highly diverse phenotypes, including (i)
defects in the circadian rhythm (Tobler et al., 1996), (ii) abnor-
mal development of infrapyramidal mossy fibers (Colling et al.,
1997), (iii) a reduced capacity to generate hematopoietic stem
cells (Zhang et al., 2006), and (iv) a peripheral neuropathy that is
most conspicuously characterized by amyelinmaintenance defect
(Bremer et al., 2010). Due to the complex nature of the biol-
ogy underlying any of these phenotypic changes, none of them
immediately suggest how PrPC might be involved. It also does
not help that each of them requires a unique environment not
easily accessible by experimental means. The only phenotype for
which a wealth of available data has provided a near-complete
Abbreviations: CRISPR, clustered regularly interspaced short palindromic
repeats; EMT, epithelial-to-mesenchymal transition; FOI, Fear-Of-Intimacy; GSK-
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neural cell adhesion molecule; PL, PrP-like; PrPC, cellular prion protein; SFK, Src
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molecular explanation constitutes the well-known resistance of
PrP-knockout mice to infection with prion disease (Sailer et al.,
1994).
This mini-review will add to this body of literature by shin-
ing a spotlight on the possibility that the prion protein may, in
some cellular contexts, operate in signaling events that influence
a shift from cell-cell to cell-substratemodes of adherence and play,
for example, a critical role during EMT. In light of the emphasis
of this special issue on research that explores the function of the
prion protein, a brief clarification of terms and concepts may be
helpful.
THE PHYSIOLOGICAL ROLE OF A PROTEIN—PHENOTYPIC
CHANGE vs. FUNCTION
Although intuitively appealing, applying the concept of “func-
tion” to a protein can be a difficult undertaking. Any protein
that emerges from ribosome-mediated translation enters into a
unique molecular life-cycle that ultimately comes to an end when
the protein is degraded. During this cycle, a protein encoun-
ters many other molecules that may impact its own biology.
Some of these may, for instance, facilitate its post-translational
maturation and folding or influence its sorting and trafficking.
The consequences of molecular interactions may be equidirec-
tional, orthogonal or opposite with regard to a specific outcome.
They may also possess other characteristics that complicate their
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study; for example, they can be transient or long-lasting, and
can qualitatively or quantitatively change over time. The net
effect of these molecular interactions will not only depend on
the physicochemical properties of the protein of interest itself,
but also on the status of the cell or multicellular entity into
which it was born. The latter will, in turn, be influenced by
the characteristics and locations of all other molecules present
at a given time. For example, there are several proteins (e.g.,
WNT5A, RACK1, SIRT1 and several F-box proteins) whose
expression levels appear to correlate with the risk to acquire cer-
tain cancers, yet the same proteins have been observed to confer
protection against cancers in other paradigms (McDonald and
Silver, 2009; Lin and Fang, 2013; Li and Xie, 2014; Wang et al.,
2014).
A phenotypic change caused by a protein can be discerned
if its molecular interactions cumulatively change the biology of
the experimental paradigm in a way that is detectable (Crusio,
2002). It follows that the description of such a phenotypic change
only becomes meaningful if a precise account of the experimental
paradigm is also provided.
What is the relationship between phenotypic change and func-
tion? The term “function” seems overused in the protein literature
in general and the prion literature in particular. Here, the use
of this term will be restricted to an immediate and context-
independent role of a protein (e.g., the capacity of substrate
phosphorylation by a kinase) and will not be employed to capture
the contribution of a protein to a broad and indirect phenotypic
change (e.g., mitosis).
When viewed in this light, the body of literature dealing
with functional assignments of the prion protein begins to look
considerably less controversial. It comes as no surprise that a
protein studied as extensively as PrPC has been observed to con-
tribute to several biological processes that give rise to diverse
phenotypes. While the phenotypic changes a protein causes
are not to be confused with its function, once the function
is known, it will hopefully reconcile a majority of these phe-
notypic changes with a consistent molecular and mechanistic
explanation.
EMT, YET ANOTHER PHENOTYPIC CHANGE THE PRION
PROTEIN MAY CONTRIBUTE TO—BUT NOT ITS FUNCTION
The term EMT refers to a complex morphogenetic reprogram-
ming of cells observed during their transition from epithelial to
mesenchymal phenotypes. EMT is naturally initiated in cells dur-
ing distinct stages of development and wound healing (Lim and
Thiery, 2012). Similar morphogenetic changes also take place
during organogenesis and in pathological conditions, including
fibrosis and cancers, where their occurrence most often corre-
lates with a higher metastasis propensity (Thiery et al., 2009).
During the EMT process, strong epithelial cell-to-cell contacts in
the form of adherens junctions gradually give way to more tran-
sient cell-to-matrix connections evident in cultured cells (referred
to as focal adhesions). As adherens junctions are dissolved, func-
tional levels of E-cadherin, their main molecular constituent,
are also reduced. Consequently, cells acquire a more fibroblast-
like morphology and gradually rely on a more dynamic molec-
ular network involving integrins for cell–matrix interactions
(Lamouille et al., 2014). During the cellular reprogramming that
accompanies EMT, the levels and/or activities of many molecules
change (Figure 1).
The notion of an involvement of PrPC in the morphogenetic
program underlying EMT emerged recently from several inde-
pendent strands of investigation, including (1) observations in
cancer paradigms that predominantly see a role of PrPC as a pro-
moter of cellular invasiveness and malignancy; (2) morpholino-
based manipulations of PrP levels undertaken in zebrafish; (3)
a subset of available PrP protein–protein interaction data; and
(4) commonalities between PrP and the subbranch of ZIP trans-
porters from which it descended. Finally, pilot data generated in
mammalian cells in which the expression of PrPC was eliminated
using CRISPR/Cas gene editing tools (Hsu et al., 2014) are also
consistent with a role of PrPC as a modulator of a cellular pro-
gram that defines the balance between cell-cell and cell-substrate
adhesion (unpublished observations, Schmitt-Ulms laboratory).
Therefore, when asked to contribute to this special issue, we
decided to take the opportunity to further investigate the mer-
its of an involvement of PrPC in EMT based on published reports.
FIGURE 1 | Schematic outlining key morphological and molecular changes that accompany EMT.
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Needless to say, no claim is made that an involvement of PrPC
in EMT, even if further substantiated experimentally, would rep-
resent its physiological function. Instead, it is hoped that this
contribution might further stimulate research that may uncover
the function of PrPC.
EVIDENCE FOR A ROLE OF PrPC IN EMT IN THE CANCER LITERATURE
In light of the central role that EMT plays in the cellular biol-
ogy that governs tumor malignancy, it may not be surprising
that some support for a possible role of PrPC in EMT can be
found in the cancer literature. Several groups have reported that
the prion protein is upregulated in a subset of human cancers
ranging from colorectal and gastric cancers to breast cancer and
glioblastomas (Mehrpour and Codogno, 2010). Furthermore, a
positive correlation has been reported between the upregulation
of PrPC and the tumorigenicity of some cancer cells, suggestive
of a more causative involvement. For instance, in one of the first
reports that tied PrPC to cancer biology, the overexpression of
PrPC was observed to promote invasive and metastatic proper-
ties of gastric cancer cell lines (Pan et al., 2006), and a more
recent report suggested that high PrPC levels can be predictive of
disease recurrence in colorectal cancers (Antonacopoulou et al.,
2010). Overall, a broad consensus seems to be emerging that
PrPC can promote key indicators of malignancy in several can-
cer paradigms. However, less information and agreement exist
at this time on the signaling pathways and molecular events
involved. Several observations suggest that PrPC may modulate
signaling downstream of TGFβ. For example, it was reported
that PrPC promotes the release of certain matrix metallopro-
teinases (Pan et al., 2006; Wurm and Wechselberger, 2006) that
are activated during TGFβ signaling and are known to pro-
mote the breakdown of the extracellular matrix, thereby lead-
ing to cell detachment. Also, researchers have proposed that
the serine/threonine kinases Erk1/2 may play a critical role
in the cancer-related signaling cascade emanating from PrPC.
This conclusion was drawn on the basis of data document-
ing that small-molecule inhibitors against key components of
the mitogen-activated protein (MAP) kinase signaling pathway
were able to rescue invasive and metastatic characteristics con-
tributed by PrPC(Pan et al., 2006; Du et al., 2013). Although an
inverse relationship between E-cadherin and PrPC levels has been
observed (Du et al., 2013), whether this relationship is merely
correlative or if PrPC causally influences E-cadherin biology has,
to our knowledge, not yet been addressed in the aforementioned
cancer paradigms.
ZEBRAFISH PrP KNOCKDOWNMODELS
To date, the most dramatic phenotypic change associated with
PrP deficiency was not reported for the mouse prion protein
but for one of its two orthologs in zebrafish (Malaga-Trillo
et al., 2009). More specifically, the morpholino-based knock-
down of PrP1 (but not PrP2) was observed to cause an arrest
of zebrafish embryogenesis at the gastrula stage in the course
of cellular rearrangements that rely on EMT. Interestingly, the
PrP1-deficient embryos do not appear to suffer from an inabil-
ity to initiate EMT; rather, they are impaired in their ability to
fully execute a cell migration program that is limited to a small
number of cells and requires re-establishing cellular contacts fol-
lowing their migration (Malaga-Trillo et al., 2009). Whereas in
normal embryos PrP1 was shown to activate Src family kinases
(SFKs) and modulate the post-transcriptional E-cadherin biol-
ogy, both of these activities were impaired in PrP1-deficient
embryos. A follow-up investigation revealed that several fea-
tures within PrP1, including the repeat domain, globular domain,
N-glycosylation sites and GPI anchor attachment signal, influ-
ence the proper positioning of PrP1 at cell-cell contacts (Solis
et al., 2013). Importantly, the phenotype does not appear to
reflect a functional specialization or idiosyncrasy of zebrafish
PrP1 because it could be rescued by the introduction of mam-
malian PrPC (Malaga-Trillo and Sempou, 2009; Malaga-Trillo
et al., 2009).
PROTEIN–PROTEIN INTERACTIONS OF PrPC WITH A KNOWN EMT
CONNECTION
Although there are divergent views regarding the significance of
protein–protein interactions of PrPC (Watts and Westaway, 2007;
Aguzzi et al., 2008; Rubenstein, 2012), there appears to be a broad
consensus that PrPC exerts some of its biological role through
its affiliation with caveolae and specialized membrane domains
referred to as lipid rafts (Naslavsky et al., 1997; Mouillet-Richard
et al., 2000). Furthermore, there is agreement that the molecu-
lar microenvironment of PrPC in neurons is dominated by cell
adhesion molecules that include neural cell adhesion molecule
(NCAM) (Walsh et al., 1989), L1, integrins and non-integrin
laminin receptors known to modulate cell-to-substrate contacts
(Gauczynski et al., 2001; Watts et al., 2009). Finally, there is a
broad consensus that signals emanating from PrPC can lead to
Fyn activation (Mouillet-Richard et al., 2000; Santuccione et al.,
2005; Toni et al., 2006; Pantera et al., 2009; Tomasi, 2010; Um
et al., 2012).
Several of these physiological interactors of the prion protein
have been implicated in EMT. NCAM, for example, has recently
been shown to be a critical regulator of EMT (Lehembre et al.,
2008; Evseenko et al., 2010). Specifically, (i) increases in the lev-
els of NCAM and (ii) a redistribution of NCAM that may involve
its detachment from fibroblast growth factor (FGF) receptors and
recruitment into caveolae and/or raft-like domains (Niethammer
et al., 2002; Santuccione et al., 2005), have been recognized as
early steps during EMT (Lehembre et al., 2008). Not surprisingly,
these changes to the cellular NCAM pool and the concomitant
upregulation of functional integrins occurring during EMT lead
to increases in signaling through Fyn (Lehembre et al., 2008).
Moreover, αV-containing integrins, another family of PrPC inter-
actors (Watts et al., 2009), are critical for activation of the EMT
master regulator TGFβ1 (Munger et al., 1999; Mu et al., 2002).
Mice harboring point mutations in the αV integrin “RGD” recog-
nition motif within the TGFβ1 preprotein (TGFβ1RGE/RGE) were
shown to phenocopy TGFβ1-null mice (Yang et al., 2007). As
an additional example, β1 integrin-L1 complexes have long been
known to play a role in controlling cellular migration processes.
More recently, L1 has been linked to EMT and a molecular biol-
ogy that determines cancer invasiveness (Kiefel et al., 2012). Thus,
the stage, players and activities that PrPC is surrounded by are
familiar to the research community studying EMT.
www.frontiersin.org September 2014 | Volume 2 | Article 53 | 3
Mehrabian et al. Role of prion protein in epithelial-to-mesenchymal transition
FUNCTION OF CLOSEST EVOLUTIONARY RELATIVES OF PrP
Members of the mammalian prion protein family (PrPC, Dpl
and Sho) were recently shown to have evolved from the family
of ZIP (Zrt-, Irt-like Protein) metal ion transporters (Schmitt-
Ulms et al., 2009), with up to 30% amino acid sequence iden-
tity observed in some pair-wise comparisons of PrP and ZIP
sequences. Subsequent work established that the founding event
of the prion gene family coincided with the speciation of early
vertebrates around 500 million years ago. This event relied on
a genomic rearrangement that involved the retroinsertion of an
ancient ZIP transcript and, probably, was mediated by retrotrans-
position elements (Ehsani et al., 2011). Amino acid sequence
comparisons revealed that PrP is most similar to ZIPs 5, 6 and
10, which constitute a distinct sub-branch within this gene fam-
ily that consists of 14 paralogs in humans (Schmitt-Ulms et al.,
2009). The primary cellular function of ZIP transporters is the
import of zinc and other divalent cations into the cytosol (Lichten
and Cousins, 2009). The PrP-like (PL) domains within ZIPs 5, 6
and 10 represent their N-terminal ectodomains and resemble PrP
with regard to orientation and relative distance to their down-
stream membrane anchorage sites. The PL domain most likely
fulfills a role as amodulator of the cation import channel to which
it is attached (Ehsani et al., 2012).
Interestingly, ZIP6 deficiency in zebrafish embryos has been
reported to give rise to a gastrulation defect that is similar to
the aforementioned defect observed in PrP1-deficient zebrafish
(Yamashita et al., 2004). Subsequent work documented that
manipulation of ZIP6 expression levels in mammalian cells leads
to equidirectional changes in levels of E-cadherin expression
(Shen et al., 2009). The close Drosophila ZIP ortholog Fear-Of-
Intimacy (FOI) (Mathews et al., 2005) has similarly been shown
to play a role in EMT-like morphogenetic cell movements under-
lying both gonad and trachea formation (Godt and Tepass, 2003;
VanDoren et al., 2003).More specifically, the zinc transport activ-
ity of FOI was shown to be essential for post-transcriptional stabi-
lization of E-cadherin expression, with loss-of-function mutants
of FOI leading to strongly reduced levels of functional E-cadherin.
This did not preclude initiation of cell migration, but interfered
with the coalescence of cells following their migration (Mathews
et al., 2006). Additional support for the notion that ZIP proteins
may affect EMT-like signaling came from a recent genetic report
of a family afflicted with a subtype of myopia, a leading cause of
blindness in humans, which identified a nonsense mutation in
the ZIP5 gene to co-segregate with the phenotype (Guo et al.,
2014). Follow-up biochemical work led the authors to observe
that ZIP5 deficiency interfered with signaling downstream of
TGFβ.
MODEL OF PrP/ZIP E-CADHERIN MODULATION
Given that the knockdown of PrP1 or its molecular cousin ZIP6
gives rise to similar gastrulation defects in zebrafish, the ques-
tion arises as to whether a primary role of the prion protein
is to modulate ZIP-dependent cation import. The evolutionary
relationship of PrP and ZIPs and the ability of ZIPs to inter-
act with PrPC are consistent with such a model (Schmitt-Ulms
et al., 2009). However, close scrutiny of the precise E-cadherin
deficiencies in the respective knockdown phenotypes may suggest
a more complex scenario. Whereas the zinc import function of
the aforementioned ZIPs appears to reduce E-cadherin levels at
the transcriptional level (Yamashita et al., 2004), PrP deficiency
in zebrafish does not seem to interfere with E-cadherin tran-
scription but may prevent E-cadherin from reaching the plasma
membrane (Malaga-Trillo et al., 2009; Solis et al., 2013). Thus,
PrP/ZIPs may influence functional E-cadherin levels by a coordi-
nated transcriptional and post-translational regulation. A plau-
sible scenario (Figure 2) sees the zinc import function of ZIPs
regulate E-cadherin gene transcription, possibly by controlling
the zinc-dependent nuclear translocation of certain transcrip-
tion factors such as the zinc finger EMT master regulator Snail
(Yamashita et al., 2004). This signaling pathway may involve
glycogen synthase kinase 3 beta (GSK-3β) (Hogstrand et al.,
2013). PrP may also act as a modulator of this ZIP-dependent
zinc import by acting as a scavenger or sensor of zinc ions (Watt
et al., 2013), or on account of its ability to acquire alternative N-
terminal folds in response to changes in its surrounding cation
milieu (Chattopadhyay et al., 2005). Metal-dependent confor-
mational changes of PrP could, for instance, modulate access
of divalent cations to the ion channel present in a nearby ZIP
protein, either by sterically blocking the channel or by exerting
an influence on the arrangement of the channel transmembrane
domains. On the other hand, PrP may serve a role in control-
ling functional E-cadherin levels post-translationally through the
activation of Fyn (Lilien and Balsamo, 2005; Smyth et al., 2012).
Assuming that PrP inherited this property from its ZIP ancestor,
and that it can still be found in contemporary ZIP transporters
equipped with a PL ectodomain, these ZIP molecules may oper-
ate as highly specialized regulators of EMT. It will be interesting
to explore if the PL ectodomain of ZIPs can influence Fyn activa-
tion similar to PrP, and if such dual capability is at play in EMT
paradigms that lack the prion protein. An example could be the
process of gonad formation in Drosophila, where the ZIP para-
log FOI is known to play a critical role in modulating E-cadherin
expression and stability (Jenkins et al., 2003; Van Doren et al.,
2003; Mathews et al., 2006). Indeed, a first indication that FOI
might influence E-cadherin biology at the transcriptional and
post-translational levels emerged from elegant in vivo functional
rescue experiments conducted with FOI-knockout flies. In con-
trast to the aforementioned ZIP6 zebrafish gastrulation paradigm,
mutant zinc import-defective derivatives of FOI were, observed
to exhibit reduced DE-cadherin expression. Significantly, forced
expression of DE-cadherin from an unrelated tubulin promoter
still did not lead to a functional rescue unless FOI was also present
to ensure the post-translational stabilization of DE-cadherin
(Mathews et al., 2006).
CONCLUSIONS
During the course of EMT, cells have to master the feat of gradu-
ally shifting their cell-cell and cell-substrate contacts from a stably
adherent to a more transient and focal mode of attachment. The
cellular program underlying these changes requires the concerted
action of many molecules. Here we reviewed evidence consis-
tent with the notion that members of the ZIP/PrP protein family
may influence this program by affecting E-cadherin biology at
multiple levels. It is likely that the cellular context will play a
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FIGURE 2 | Schematic summarizing evidence consistent with a role of
PrPC in EMT. (1) The closest molecular cousins of PrP from the ZIP zinc
transporter family possess a documented role in EMT. Knockout or
knockdown phenotypes of the respective ZIPs in zebrafish, Drosophila or
mammalian cells demonstrate a critical role of ZIP-dependent zinc import in
the transcriptional control of the E-cadherin gene. Note that whereas in the
zebrafish EMT paradigm this transcriptional control is orchestrated by the
EMT master regulator Snail and suppresses E-cadherin expression, the zinc
import function of the Drosophila FOI gene was observed to promote
E-cadherin transcription during gonad organogenesis (not shown). (2) Multiple
interactors of PrPC with a known ability to modulate the activity of Fyn (a Src
family kinase) are independently known to play a role in EMT. (3) PrP
knockdown in zebrafish is characterized by a gastrulation arrest phenotype
with cytoplasmic accumulation of E-cadherin.
critical role for the direction and extent to which the expression
of ZIPs/PrP affects this biology. With the advent of novel genome
editing technologies and advances in quantitative protein mass
spectrometry, the involvement of PrP in EMT and related cellu-
lar processes can now be studied much more elegantly. It is to
be expected that these efforts will in the not-too-distant future
lead to a much more detailed understanding of the cellular path-
ways that underlie phenotypic changes observed in PrP knockout
paradigms and, ultimately, reveal the molecular function of this
protein.
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